CEO LEADERSHIP SERIES
ASHTON TWEED'S CEO INTERVIEWS
March 22, 2019
HOW A CLINICAL TRIAL TECH COMPANY BALANCES GROWTH AND BUILDS CREDIBILITY Clinical Ink, a global clinical trial technology company based in Horsham, PA., is on a […]
November 9, 2018
PIVOTAL DECISION BRINGS NEW HORIZONS AND CHALLENGES After a long career in the pharmaceutical industry, Robert Bitterman decided to launch his own dermatology company, Cutanea Life […]
February 25, 2018
WHY FOCUS IS BOTH AN ASSET AND A CHALLENGE FOR THIS STARTUP Onkos Surgical, based in Parsippany, N.J., just hired its 34th employee, each one carefully […]
October 16, 2017
HOW TO CREATE SUCCESS AMID BIOTECH INDUSTRY’S UPS AND DOWNS When Dr. Geert Cauwenbergh became the President and CEO of RXi Pharmaceuticals Corp., he brought decades […]
August 21, 2017
SUPPORTING INNOVATION IN A RAPIDLY EVOLVING INDUSTRY In 1994, Debbie Hart became the founding president of BioNJ, a trade group that initially represented approximately 30 biotech […]
July 7, 2017
HOW TO INFLUENCE A COMPANY’S CULTURE AND WHY IT MATTERS In his 27 years as a biotech and pharmaceutical professional, James Caruso has held key executive […]
April 7, 2017
WALKING A TIGHTROPE BETWEEN DRUG DEVELOPMENT AND FUNDRAISING For Christopher J. Schaber, helming Soligenix Inc. involves walking a tightrope between developing a [...]
February 27, 2017
HOW TO MAKE TOUGH DECISIONS AND HELP OTHERS SUCCEED In the three years since Cynthia Schwalm joined Ipsen’s North America operations, she’s handled the enviable challenge […]
January 3, 2017
HOW TO TRANSITION FROM AN R&D TO CLINICAL-STAGE CULTURE During the 11 years that Dr. Elizabeth G. “Tibby” Posillico has been President and CEO of Elusys Therapeutics, […]
November 17, 2016
INVESTING IN THE FUTURE OF CANCER TREATMENT After co-founding and building Morphotek, Inc., a biotech company that specializes in developing biologics for the treatment of oncology, infectious […]
September 26, 2016
HOW WHEN PERSEVERANCE AND PASSION FINALLY PAY OFF When Scott Jackson became CEO of Celator Pharmaceuticals, Inc. more than eight years ago, a new treatment for […]
August 19, 2016
HOW A MERGER JUMP-STARTED A PROMISING DRUG’S DEVELOPMENT Gur Roshwalb, M.D., isn’t afraid of a challenge. When Dr. Roshwalb, CEO of Akari Therapeutics Plc, saw a […]
ARE YOU A CEO INTERESTED IN JOINING OUR LEADERSHIP SERIES?
CONTACT US TO DISCUSS AN INTERVIEW:
Partner, Ashton Tweed Ltd.
Phone: 610.725.0290 x441
Ashton Tweed, Ltd.
314 S. Henderson Rd.
King of Prussia, PA 19406